CN Patent

CN101506221B — 雌三烯衍生物及其作为17β-羟基类固醇脱氢酶抑制剂的用途

Assigned to Abbott Healthcare Products BV · Expires 2012-09-12 · 14y expired

What this patent protects

本发明涉及新型的通式(I)的雌三烯-三唑类化合物，其可用于治疗中，尤其是用于治疗和/或预防类固醇激素依赖性疾病，优选需要抑制17β-羟基类固醇脱氢酶(17β-HSD)如1型、2型或3型17β-HSD酶的类固醇激素依赖性疾病或障碍。

USPTO Abstract

本发明涉及新型的通式(I)的雌三烯-三唑类化合物，其可用于治疗中，尤其是用于治疗和/或预防类固醇激素依赖性疾病，优选需要抑制17β-羟基类固醇脱氢酶(17β-HSD)如1型、2型或3型17β-HSD酶的类固醇激素依赖性疾病或障碍。

Drugs covered by this patent

Patent Metadata

Patent number
CN101506221B
Jurisdiction
CN
Classification
—
Expires
2012-09-12
Drug substance claim
No
Drug product claim
No
Assignee
Abbott Healthcare Products BV
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.